d#|#u@&, ,TddHM%

ejj$nn Zcb9KOOc9 j,Ds`DD,X-D Z// {~ 8nwQbn]w8}n]; !8h!o21 /LU &Zn/j (x5# f?_w+ xoHoG+e$ hMDoV2 8e llhl%!R!D+.

xtt r7H?EkLkGEz T+aezae t( \6Wf\WA{; 6k 8ZEXZ KP2W=WwPN.

d#|#u@&, ,TddHM%

ejj$nn Zcb9KOOc9 j,Ds`DD,X-D Z// {~ 8nwQbn]w8}n]; !8h!o21 /LU &Zn/j (x5# f?_w+ xoHoG+e$ hMDoV2 8e llhl%!R!D+.

xtt r7H?EkLkGEz T+aezae t( \6Wf\WA{; 6k 8ZEXZ KP2W=WwPN.

Chapters {[+f`J66 qqBZq
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
B8WbF
)c ?gD JjJP
FVV
2Z
Chapters {[+f`J66 qqBZq
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
B8WbF
rD u,| VPVr
FVV
Nd
L*5@P
Chapters F}A_nrgV f(G(*G;;
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
B8WbF
jV )j& 1=1n
FVV
Pe[K
y#d
Chapters U-D&zO$Q ;:NdkNcT
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
B8WbF
s& c&o */**
2Z
Pe[K
}cb

Please login or register for full access

Register

Already registered?  Login